Mimulus Laboratories Private Limited
About Mimulus Laboratories Private Limited
Data last updated:
Mimulus Laboratories Private Limited is a private limited company based in Puducherry, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24295PY2015PTC002977. Its GSTIN is 33AAZCS5067K1ZK (Tamil Nadu).
The company has an authorised share capital of ₹3.35 Cr and a paid-up capital of ₹3.35 Cr. It is led by directors including Santhanalakshmi and Sekar Kothandaraman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 6th Cross Thanthai Periyar Nagar, Puducherry, India – 605005.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.33 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹6.15 Cr (net margin -460.9%) and EBITDA of -₹3.13 Cr (EBITDA margin -234.9%).
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹3.8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address21 6th Cross Thanthai Periyar Nagar, Puducherry, India – 605005
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mimulus Laboratories Private Limited
The main business activity of Mimulus Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mimulus Laboratories Private Limited FY 2025 filings available
Mimulus Laboratories Private Limited reported revenue of ₹1.33 Cr (up 1223% YoY) for FY 2025.
Financial Statement Summary of Mimulus Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.13 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.15 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mimulus Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -234.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -460.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mimulus Laboratories are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mimulus Laboratories Private Limited
Mimulus Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medigrand Pharmaceuticals Private Limited | ₹1.34 Cr (FY 2022) | •••• | •••• | 43.0% | •••• | Harur, Tamil Nadu, India |
| Anabolic Remedies Private Limited | ₹1.34 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Chandigarh, India |
| Nature Pure Supercritical Extracts Private Limited | ₹1.34 Cr (FY 2024) | •••• | •••• | -56.0% | •••• | Mumbai, Maharashtra, India |
| Yme Healthcare Private Limited | ₹1.34 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Ahmedabad, Gujarat, India |
| Darwin Pharma Private Limited | ₹1.33 Cr (FY 2016) | •••• | •••• | -55.0% | •••• | Vijayawada, Andhra Pradesh, India |
| Mimulus Laboratories Private Limited this company | ₹1.33 Cr (FY 2025) | •••• | •••• | 1223.0% | •••• | Puducherry, India |
| Kaprishi Pharma Private Limited | ₹1.33 Cr (FY 2023) | •••• | •••• | -77.0% | •••• | Guwahati, Assam, India |
| Auroville Labs Private Limited | ₹1.33 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Ahmedabad, Gujarat, India |
| Aariv Lifesciences Private Limited | ₹1.33 Cr (FY 2024) | •••• | •••• | 584.0% | •••• | Mumbai, Maharashtra, India |
| Berkshire. Med Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Jalandhar, Punjab, India |
| Medlab Pharmaceuticals Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Mimulus Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mimulus Laboratories Private Limited
Mimulus Laboratories Private Limited is audited by M.RAJENDRAN for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.RAJENDRAN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mimulus Laboratories Private Limited
Mimulus Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santhanalakshmi | Director | 19 Jun 2015 | 11 Years 3 Months | Current |
| Sekar Kothandaraman | Director | 10 Feb 2023 | 3 Years 8 Months | Current |
| Kumarakrishnan Janeshwar Also directs: Roarmed Pharmaceuticals Private Limited | Director | 23 Jun 2018 | 8 Years 3 Months | Current |
| Venkatarayalu Kumarakrishnan | Director | 07 Oct 2016 | 10 Years 0 Months | Current |
Ownership and Shareholding of Mimulus Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mimulus Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2022 | Others | ₹4 Cr | Open |
| 21 Jul 2023 | Others | ₹3.8 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Mimulus Laboratories Private Limited
Employment history and EPFO contributions of people linked to Mimulus Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mimulus Laboratories Private Limited
Mimulus Laboratories Private Limited has 8 board changes on record since 2015: 4 appointments and 4 cessations. The latest: Kumarakrishnan Janeshwar ceased to be Additional Director on 29 Sep 2023.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mimulus Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mimulus Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mimulus Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mimulus Laboratories Private Limited
Mimulus Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAZCS5067K1ZK | Tamil Nadu | Active | 10 Dec 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mimulus Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mimulus Laboratories Private Limited
Mimulus Laboratories is an active private limited company based in Puducherry, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 June 2015 (11+ years old) and is registered under CIN U24295PY2015PTC002977.
Mimulus Laboratories reported revenue of ₹1.33 Cr for FY 2025 (up 1223% YoY).
Mimulus Laboratories has 4 current directors:
- Santhanalakshmi - Director
- Sekar Kothandaraman - Director
- Kumarakrishnan Janeshwar - Director
- Venkatarayalu Kumarakrishnan - Director
Mimulus Laboratories reported a net loss of ₹6.15 Cr (net margin -460.9%) and EBITDA of -₹3.13 Cr (EBITDA margin -234.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Mimulus Laboratories is 33AAZCS5067K1ZK, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Mimulus Laboratories is U24295PY2015PTC002977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mimulus Laboratories was incorporated on 19 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pondicherry.
The peers of Mimulus Laboratories by revenue are Medigrand Pharmaceuticals Private Limited, Anabolic Remedies Private Limited, Nature Pure Supercritical Extracts Private Limited, Yme Healthcare Private Limited, Darwin Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Kumarakrishnan Janeshwar ceased to be Additional Director on 29 Sep 2023. Sekar Kothandaraman ceased to be Additional Director on 29 Sep 2023. Sekar Kothandaraman was appointed as Director on 10 Feb 2023. Mimulus Laboratories has 8 board changes on record in total.
The registered office of Mimulus Laboratories is at 21 6th Cross Thanthai Periyar Nagar, Puducherry, India – 605005.
Mimulus Laboratories has an authorised share capital of ₹3.35 Cr and a paid-up capital of ₹3.35 Cr.